Vascular endothelial growth factor (VEGF) is the main downstream target of HIF1α for blood vessel formation, and TTFs have been found to decrease the expression of both HIF1α and VEGF in GBM tumors [33, 41]. Here, VEGFA is linked to glioblastoma.